Evidence map›Paper›PMID 40293674›Full record

ArticleJournal of ultrasound2026

B-mode and contrast-enhanced ultrasound versus magnetic resonance imaging in hepatic angiomyolipoma: a case report.

Andrea Balbinot, Sofia Maria Bakken, Nicola Venturoli, Deborah Malvi, Elisa Albertini, Maria Giulia Pirini, Antonietta D'Errico, Carla Serra

Abstract readCase ReportsComparative Study
In one paragraph

Article in Journal of ultrasound, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrea BalbinotCardiovascular Medicine Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Sofia Maria BakkenDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. sofiamaria.bakken2@unibo.it.ORCID http://orcid.org/0009-0001-0860-1324
Nicola VenturoliDiagnostic and Therapeutic Interventional Ultrasound Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Deborah MalviPathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Elisa AlbertiniPathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Maria Giulia PiriniPathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Antonietta D'ErricoDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
Carla SerraDiagnostic and Therapeutic Interventional Ultrasound Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiomyolipoma is a solid mesenchymal tumour that usually affects the kidney. Hepatic localization of angiomyolipoma (HAML) is rare and usually asymptomatic however it presents a challenging differential diagnosis. We present the case of a 45-year-old man affected by tuberous sclerosis complex type 2 (TSC2) and an hepatic lesion suspected to be hepatocellular carcinoma on magnetic resonance but whose Bmode ultrasound and contrast-enhanced ultrasound (CEUS) findings were consistent with benignity, as confirmed by histology.

Indexed as

AngiomyolipomaLiver NeoplasmsMagnetic Resonance ImagingContrast MediaDiagnosis, DifferentialHumansMaleMiddle AgedTuberous SclerosisUltrasonographyContrast MediaCEUSHCCHepatic angiomyolipomaTuberous sclerosisUltrasound-guided biopsy

Identifiers

PMID40293674
PMCPMC13000067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.